Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Donati

Showing results (51-60 of 476) with videos related to

Pageof 48
Sort By:
British Journal of Cancer|March 5, 2004
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapyA Gennari, P Bruzzi, C Orlandini, et al.
Oncology (Williston Park, N.Y.)|March 17, 2001
The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancerP Conte, B Salvadori, S Donati, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Early Assessment by PET with FDG of Response to First-Line Chemotherapy of Metastatic Breast CancerG Mariani, A Gennari, A Giorgetti, et al.
Minerva Medica|September 19, 1971
[Clinical use and results of immunodepressive treatment with anti-lymphocyte immunoglobulins in human renal allotransplantation]C Scotti-Foglieni, A Salvadeo, R Cortinovis, et al.
Clinical and Experimental Immunology|December 17, 2008
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycinF Nicoletti, C Lapenta, C Lamenta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2009
Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance statusA Camerini, C Valsuani, F Mazzoni, et al.
Breast Cancer Research and Treatment|November 2, 2001
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II studyP F Conte, A Gennari, S Donati, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2008
The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabineS Lopatriello, D Amoroso, S Donati, et al.
The Journal of Endocrinology|March 8, 2005
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penisX H Zhang, S Filippi, L Vignozzi, et al.
Journal of Endocrinological Investigation|October 7, 2019
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safeS Rosetti, M L Tanda, G Veronesi, et al.
Pageof 48

Showing results (51-60 of 476) with videos related to

Sort By:
Pageof 48
British Journal of Cancer|March 5, 2004
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapyA Gennari, P Bruzzi, C Orlandini, et al.
Oncology (Williston Park, N.Y.)|March 17, 2001
The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancerP Conte, B Salvadori, S Donati, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Early Assessment by PET with FDG of Response to First-Line Chemotherapy of Metastatic Breast CancerG Mariani, A Gennari, A Giorgetti, et al.
Minerva Medica|September 19, 1971
[Clinical use and results of immunodepressive treatment with anti-lymphocyte immunoglobulins in human renal allotransplantation]C Scotti-Foglieni, A Salvadeo, R Cortinovis, et al.
Clinical and Experimental Immunology|December 17, 2008
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycinF Nicoletti, C Lapenta, C Lamenta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2009
Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance statusA Camerini, C Valsuani, F Mazzoni, et al.
Breast Cancer Research and Treatment|November 2, 2001
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II studyP F Conte, A Gennari, S Donati, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2008
The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabineS Lopatriello, D Amoroso, S Donati, et al.
The Journal of Endocrinology|March 8, 2005
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penisX H Zhang, S Filippi, L Vignozzi, et al.
Journal of Endocrinological Investigation|October 7, 2019
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safeS Rosetti, M L Tanda, G Veronesi, et al.
Pageof 48